Fundraising FoxCultivation Capital — 2017 Investments
5 investments dated 2017 · listed companies and verified rows first · show all
Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing.
AgTechBiotechHealthtechChampaign, US
Aaron Gilbertie(CEO)Federico Zuckermann(Executive Officer, Director)
BoardRobert Easter(Director)Paul Olivo(Director)Gary Durack(Director)
Co-investorsMissouri Technology CorporationArsenalThe Yield LabBioGenerator VenturesIllinois VenturesThe Yield Lab Asia Pacific
NarrativeDx is an Austin-based AI platform that analyzes unstructured patient feedback for hospitals and health systems.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSAustin, US
Senem Guney(Executive Officer, Director)Kyle Robertson(Executive Officer, Director)Patrick Ryan(Chairman and Chief Executive Officer)inNell Buhlman(Chief Strategy Officer)inDarren Dworkin(President and Chief Operating Officer)inKyle Ferguson(President and Chief Commercial Officer)in
Co-investorsBCIExcelerate Health VenturesHealthX VenturesLeonard GreenLiveOak VenturesTechstars+2 more
SentiAR builds CommandEP, an FDA-cleared mixed-reality holographic augmented reality platform for cardiac electrophysiology that converts real-time catheter data into hands-free 3D holograms and virtual screens for electrophysiologists during procedures.
AI & Machine LearningHealthtechMedical DevicesSt. Louis, US
Jonathan Silva(Executive Officer, Director)Berk Tas(Executive Officer, Director)inJames Patrick Howard(Executive Officer)
BoardSean Churchill(Director)Warren Watson(Director)
Co-investorsMissouri Technology CorporationBioGenerator VenturesHarmonix FundMedVenture Partners, Inc.Service Provider Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.